APA (7th ed.) Citation

Ma, Y., Li, Y., Lin, Z., Wang, J., Hu, J., Liu, H., . . . Zhang, T. Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis. BMC.

Chicago Style (17th ed.) Citation

Ma, Yuxi, Yuting Li, Zhenyu Lin, Jing Wang, Jianli Hu, Hongli Liu, Yali Yang, Junli Liu, and Tao Zhang. Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination with Intravenous or Intraperitoneal Bevacizumab in Gastric Cancer with Peritoneal Metastasis. BMC.

MLA (9th ed.) Citation

Ma, Yuxi, et al. Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination with Intravenous or Intraperitoneal Bevacizumab in Gastric Cancer with Peritoneal Metastasis. BMC.